Who Is Dr. Chen Saijuan?
Dr. Chen Saijuan (陈赛娟) is an Academician of the Chinese Academy of Sciences and one of the world's leading authorities in leukemia genetics and precision hematology at Ruijin Hospital, affiliated with Shanghai Jiao Tong University School of Medicine. A pioneer in the molecular understanding and targeted treatment of acute promyelocytic leukemia (APL), Dr. Chen's research has contributed directly to the development of the world-famous "Shanghai Protocol" — an arsenic trioxide and all-trans retinoic acid (ATRA) combination therapy that has transformed APL from a highly fatal disease into one of the most curable leukemias in the world. Her work alongside colleague Dr. Zhao Weili makes Ruijin Hospital's Hematology Department one of the most formidable blood cancer centers in Asia.
What Conditions Does She Treat?
Dr. Chen Saijuan specializes in the molecular diagnosis and precision treatment of hematological malignancies, with particular expertise in:
- Acute promyelocytic leukemia (APL) — including relapsed and refractory cases
- Acute myeloid leukemia (AML) — molecular subtyping and targeted therapy
- Acute lymphoblastic leukemia (ALL)
- Myelodysplastic syndromes (MDS) with molecular characterization
- Chronic myeloid leukemia (CML) and TKI therapy optimization
- Leukemia with complex cytogenetics or molecular mutations (FLT3, NPM1, IDH1/2, etc.)
- CAR-T cell therapy candidacy evaluation
- Genetic counseling for hereditary hematological conditions
Why International Patients Choose Dr. Chen
International patients seek Dr. Chen Saijuan for her unparalleled expertise in the molecular biology of leukemia and her ability to design precision treatment plans based on the specific genetic and molecular profile of each patient's disease. For patients with APL, AML, or other leukemias that have relapsed or failed standard therapy, Dr. Chen's team offers access to cutting-edge molecular diagnostics, novel targeted agents, and clinical trials that may not be available elsewhere. Her research-driven approach means patients benefit from the very latest advances in precision hematology — often before these treatments become widely available globally.
How CMCS Arranges Your Appointment
CMCS manages every aspect of your medical visit so you can focus entirely on your health. Here's how we help:
- Initial Consultation: Contact CMCS and share your pathology reports, bone marrow biopsy results, cytogenetics, and molecular testing results.
- Case Review: Our team reviews your case and confirms the most appropriate specialist — Dr. Chen Saijuan or a senior member of her team.
- Appointment Booking: We coordinate directly with Ruijin Hospital to secure your consultation, including urgent cases when needed.
- Pre-Visit Preparation: We advise on which pathology materials, molecular test results, and treatment records to bring or send in advance.
- On-the-Day Support: A CMCS coordinator accompanies you through registration, consultation, and any same-day tests or bone marrow procedures.
- Treatment Coordination: If treatment at Ruijin is recommended, CMCS helps coordinate hospital admission, chemotherapy scheduling, and ongoing care logistics.
What to Prepare Before Your Visit
To ensure the most productive consultation with Dr. Chen Saijuan, please prepare:
- Complete bone marrow biopsy report including morphology, immunophenotyping (flow cytometry), cytogenetics (karyotype, FISH), and molecular testing (PCR, NGS panel)
- PML-RARα fusion gene result (for APL patients)
- Recent blood counts: CBC with differential, coagulation profile (DIC screen for APL)
- Records of all prior treatment: chemotherapy regimens, response assessments, and any prior transplant
- Pathology slides (original bone marrow trephine biopsy slides if possible)
- A full list of current medications
- Your passport and travel/health insurance documents
What to Expect on the Day
Ruijin Hospital's Hematology Department is one of the most advanced blood cancer centers in Asia, with comprehensive molecular diagnostics, a dedicated leukemia research laboratory, and access to novel clinical trials. Your consultation with Dr. Chen's team will involve a thorough review of your molecular and pathological data, followed by a detailed discussion of your diagnosis, prognosis, and precision treatment options. CMCS will ensure all communication is clear and that you leave with a complete understanding of your disease and the recommended treatment plan. For patients requiring multidisciplinary input, we can coordinate with Dr. Zhao Weili's team or other specialist departments within Ruijin Hospital seamlessly.
Contact CMCS to Get Started
Ready to book your consultation with Dr. Chen Saijuan at Ruijin Hospital? Reach out to our team today:
CMCS is your trusted medical concierge partner in Shanghai — making world-class Chinese healthcare accessible to international patients.
댓글 0개